Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Oncternal Therapeutics Inc. buy blaugold

Oncternal Therapeutics Inc.
Start price
€2.70
21.11.21 / 50%
Target price
-
21.11.22
Performance (%)
-4.30%
End price
€2.58
27.11.21
Summary
This prediction ended on 27.11.21 with a price of €2.58. With a performance of -4.30%, the BUY prediction by blaugold finished with a loss. blaugold has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Oncternal Therapeutics Inc. - - -
iShares Core DAX® -1.670% -1.001% 10.864%
iShares Nasdaq 100 -4.184% -1.145% 37.458%
iShares Nikkei 225® -4.967% -5.783% 18.828%
iShares S&P 500 -2.834% -0.572% 25.875%

According to blaugold what are the pros and cons of Oncternal Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by blaugold for this prediction

In the thread Oncternal Therapeutics Inc. diskutieren

Buy Oncternal Therapeutics Inc.

blaugold 
0
Report Share
21.11.21 Buy -4.30%
In the thread Trading Oncternal Therapeutics Inc.
Prediction Buy
Perf. (%) -4.30%
Target price
Change
Ends at 21.11.22

Buy beendet

blaugold 
0
Report Share
27.11.21

Stopped prediction by blaugold for Oncternal Therapeutics Inc.

buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.81
09.01.22
-
09.01.23
-12.41%
23.01.22

Could be very worthwhile Investment >20% year
blaugold 
09.01.22 50%
buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.61
12.12.21
-
12.12.22
-18.44%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%